Grantham, Mayo, Van Otterloo & Co (GMO)’s iShares MSCI Emerging Markets ex China ETF EMXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.42M Buy
14,292
+2,345
+20% +$227K ﹤0.01% 492
2026
Q2
$1.22M Buy
11,947
+1,130
+10% +$107K ﹤0.01% 497
2026
Q1
$851K Buy
10,817
+161
+2% +$12.9K ﹤0.01% 519
2025
Q4
$774K Buy
+10,656
New +$756K ﹤0.01% 545
2025
Q1
– Sell
-13,251
Closed -$735K – 637
2024
Q4
$735K Sell
13,251
-87,027
-87% -$5.11M ﹤0.01% 476
2024
Q3
$6.13M Buy
+100,278
New +$6.02M 0.02% 307

Other funds holding EMXC

Grantham, Mayo, Van Otterloo & Co (GMO)'s EMXC Position: Q3 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its iShares MSCI Emerging Markets ex China ETF (EMXC) stake by 20% in Q3 2026, buying an estimated $227K and bringing the position to 14,292 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #492.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in EMXC in Q3 2024 and has held it in 6 quarters since. The position peaked at $6.13M in Q3 2024. 1,019 funds tracked by Wall St. Rank hold EMXC as of Q3 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 14,292 shares of iShares MSCI Emerging Markets ex China ETF worth $1.42M as of Q3 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 2,345 iShares MSCI Emerging Markets ex China ETF shares in Q3 2026, an estimated $227K.
  • iShares MSCI Emerging Markets ex China ETF made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q3 2026, its #492 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in iShares MSCI Emerging Markets ex China ETF in Q3 2024 and has held it in 6 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s iShares MSCI Emerging Markets ex China ETF position peaked at $6.13M in Q3 2024.
  • 1,019 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ex China ETF as of Q3 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2026, filed 13 Nov 2026.